- Home
- NOTV vs LPSN Comparison
NOTV vs LPSN Comparison
Compare NOTV & LPSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NOTV
- LPSN
- Stock Information
- Founded
- NOTV 1974
- LPSN 1995
- Country
- NOTV United States
- LPSN United States
- Employees
- NOTV N/A
- LPSN N/A
- Industry
- NOTV Biotechnology: Pharmaceutical Preparations
- LPSN EDP Services
- Sector
- NOTV Health Care
- LPSN Technology
- Exchange
- NOTV Nasdaq
- LPSN Nasdaq
- Market Cap
- NOTV 62.5M
- LPSN 72.8M
- IPO Year
- NOTV 1997
- LPSN 2000
- Fundamental
- Price
- NOTV $1.76
- LPSN $0.99
- Analyst Decision
- NOTV Strong Buy
- LPSN Hold
- Analyst Count
- NOTV 1
- LPSN 3
- Target Price
- NOTV $5.00
- LPSN $1.20
- AVG Volume (30 Days)
- NOTV 448.8K
- LPSN 1.7M
- Earning Date
- NOTV 08-07-2025
- LPSN 07-30-2025
- Dividend Yield
- NOTV N/A
- LPSN N/A
- EPS Growth
- NOTV N/A
- LPSN N/A
- EPS
- NOTV N/A
- LPSN N/A
- Revenue
- NOTV $480,402,000.00
- LPSN $292,025,000.00
- Revenue This Year
- NOTV $4.99
- LPSN N/A
- Revenue Next Year
- NOTV $5.39
- LPSN $0.82
- P/E Ratio
- NOTV N/A
- LPSN N/A
- Revenue Growth
- NOTV N/A
- LPSN N/A
- 52 Week Low
- NOTV $1.15
- LPSN $0.61
- 52 Week High
- NOTV $6.48
- LPSN $2.08
- Technical
- Relative Strength Index (RSI)
- NOTV 37.59
- LPSN 59.66
- Support Level
- NOTV $1.76
- LPSN $0.89
- Resistance Level
- NOTV $1.94
- LPSN $1.06
- Average True Range (ATR)
- NOTV 0.15
- LPSN 0.08
- MACD
- NOTV -0.01
- LPSN -0.00
- Stochastic Oscillator
- NOTV 10.66
- LPSN 46.55
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.
About LPSN LivePerson Inc.
LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Company's enterprise-class digital customer conversation platform, is trusted by the world's top brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United Kingdom, Asia-Pacific, Latin America, and Europe.